Phase I study of GEM or S-1 adjuvant therapy after hemihepatectomy for biliary tract cancer (KHBO1003)
Phase 1
- Conditions
- Biliary Tract Cancer (Including intrahepatic cholangiocarcinoma)
- Registration Number
- JPRN-UMIN000004682
- Lead Sponsor
- Kansai Hepatobiliary Oncology Group (KHBO)
- Brief Summary
Cancer Chemother Pharmacol. 2014 Oct;74(4):699-709
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active double cancer 2) Severe drug allergy 3) Severe complications (IP, HF, RF, LF, ileus, DM, etc) 4) Active infections 5) Pregnancy 6) Severe mental disorder 7) Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method